Quick Answer
Evolent Health, Inc. reported Operating Income Loss of -$410.14 million for the year ending 2025.
- Evolent Health, Inc. showed a decrease of -913.1% in Operating Income Loss from 2024 to 2025.
- This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: $0.00 | Q3 2014: $0.00 | Q1 2015: $0.00 | Q2 2015: -$11.54 million | Q3 2015: -$17.25 million | Q1 2016: -$175.08 million | Q2 2016: -$12.63 million | Q3 2016: -$15.84 million | Q1 2017: -$21.46 million | Q2 2017: -$19.12 million | Q3 2017: -$14.02 million | Q1 2018: -$14.13 million | Q2 2018: -$8.97 million | Q3 2018: -$11.03 million | Q1 2019: -$46.65 million | Q2 2019: -$25.23 million | Q3 2019: -$20.14 million | Q1 2020: -$25.09 million | Q2 2020: -$225.83 million | Q3 2020: -$16.45 million | Q1 2021: -$15.95 million | Q2 2021: -$7.67 million | Q3 2021: -$6.58 million | Q1 2022: -$2.80 million | Q2 2022: -$4.63 million | Q3 2022: $12.95 million | Q1 2023: -$10.36 million | Q2 2023: -$21.57 million | Q3 2023: -$17.94 million | Q1 2024: -$13.41 million | Q2 2024: $7.79 million | Q3 2024: -$16.27 million | Q1 2025: -$1.62 million | Q2 2025: -$1.17 million | Q3 2025: $886.0 thousand.
- Over the full 13 years of available data (2013 to 2025), Evolent Health, Inc.'s Operating Income Loss has declined by 1,838.7%.
- Historical annual values: Fiscal year 2025: -$410.14 million | Fiscal year 2024: -$40.49 million | Fiscal year 2023: -$71.21 million | Fiscal year 2022: $3.64 million | Fiscal year 2021: -$42.41 million | Fiscal year 2020: -$262.85 million | Fiscal year 2019: -$308.89 million | Fiscal year 2018: -$47.48 million | Fiscal year 2017: -$72.84 million | Fiscal year 2016: -$237.42 million | Fiscal year 2015: -$42.97 million | Fiscal year 2014: $0.00 | Fiscal year 2013: -$21.16 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: